Rate My Professor Jin Meng Xiang-

Meng's research program investigates the molecular virology of emerging and zoonotic viruses, elucidating mechanisms of replication, pathogenesis, cross-species transmission, and developing prophylactic and therapeutic interventions including vaccines. His laboratory discovered the swine hepatitis E virus (PNAS, 1997), proving HEV zoonotic transmission from pigs to humans, and the avian HEV from chickens. They also invented the first USDA fully-licensed commercial PCV2 vaccine, marketed worldwide against porcine circovirus-associated disease. Current studies include HEV genotypes, PCV2, Torque teno sus virus, PRRSV, and PEDV. With over 362 peer-reviewed publications, h-index of 103, and 38,685 citations, Meng ranks among the top 1% most highly cited scientists in microbiology. He is inventor on over 20 U.S. patents. Recognitions include election to the National Academy of Sciences (2016), American Association for the Advancement of Science Fellow (2022), NIH MERIT Award (2024), SCHEV Outstanding Faculty Award (2017), Fellow of the American Academy of Microbiology (2012), and University Distinguished Professor title.